Plantar Fasciitis Treatment Market - By Treatment Type (Medication [NSAIDs, Corticosteroid, Topical], Therapy [Shockwave {ESWT, IPST}, Orthotic, Ultrasound], Surgery), Indication (Mild, Moderate, Severe), End-use - Global Forecast, (2024 - 2032)

Plantar Fasciitis Treatment Market - By Treatment Type (Medication [NSAIDs, Corticosteroid, Topical], Therapy [Shockwave {ESWT, IPST}, Orthotic, Ultrasound], Surgery), Indication (Mild, Moderate, Severe), End-use - Global Forecast, (2024 - 2032)

Plantar Fasciitis Treatment Market size will grow at 9.3% CAGR during 2024-2032, driven by the rising burden of obesity. According to WHO, in 2022, approximately 16% of adults worldwide were classified as obese. Sedentary lifestyles, often accompanied by prolonged periods of inactivity and inadequate physical exercise, place undue strain on the feet, exacerbating conditions, such as plantar fasciitis. Moreover, obesity adds to the burden by increasing pressure on the feet and altering biomechanics, thereby elevating the risk of developing foot-related ailments.

As these lifestyle factors become more pervasive globally, the incidence of plantar fasciitis is expected to rise, further driving the demand for effective treatment options. Healthcare providers and stakeholders are also increasingly recognizing the need to address these underlying lifestyle factors in conjunction with medical interventions to mitigate the impacts of the condition and improve patient outcomes.

The plantar fasciitis treatment market is classified into treatment type, indication, end-use and region.

By treatment type, the medication therapy segment will grow at robust CAGR through 2032 as it helps to alleviate pain and inflammation. The effectiveness of corticosteroid injections in providing rapid relief to patients has led to their widespread adoption in clinical practice. Moreover, the convenience and relatively low cost of medication therapies will further contribute to their popularity among both patients and healthcare providers.

Based on indication, the plantar fasciitis treatment market from the moderate segment will rise at a steady pace by 2032, characterized by persistent pain and discomfort that may impair daily activities but typically do not necessitate surgical intervention. Patients with moderate symptoms often seek conservative treatment options, including physical therapy, orthotic devices, and medication. Physical therapy plays a crucial role in improving foot biomechanics, strengthening muscles, and promoting proper gait patterns, all of which contribute to pain reduction and functional improvement.

Europe plantar fasciitis treatment industry will grow at a steady pace up to 2032, driven by the large patient population and well-established healthcare infrastructure, facilitating access to diagnosis and treatment services. The increasing healthcare expenditure has led to the growing emphasis on preventive care. Countries, such as Germany, the U.K., and France are also expected to witness significant demand for plantar fasciitis treatment solutions, driven by aging population and the prevalence of risk factors, such as obesity and sedentary lifestyles.